OostNL

OostNL is a development company based in Apeldoorn, Netherlands, dedicated to strengthening the regional economies of Gelderland and Overijssel. Established in 2003, it invests public funds in entrepreneurs across various sectors, including food, energy, health, logistics, and technology. In addition to financial support, OostNL provides knowledge, expertise, and a robust network to facilitate innovation and growth among businesses. The organization emphasizes a balance between financial returns and social impact, aiming to foster sustainable economic development and job creation. By focusing on sustainability, smart industry, and health-related initiatives, OostNL aims to address global social challenges while promoting entrepreneurship and internationalization in the region.

72 past transactions

Pro Parents

Venture Round in 2025
Operator of an employer benefit platform intended for parents at work. The company's platform provides training, coaching and improvement programs which include providing maternal and paternal health and workplace wellbeing services, enabling employers to create a healthy work culture and living.

Glampings.com

Seed Round in 2025
Glampings.com is a prominent European platform dedicated to helping individuals discover and book unique glamping experiences across the continent. The company offers a diverse range of accommodations, including luxury safari tents and adventurous tree houses, ensuring that users can find the perfect setting for their outdoor holiday. Glampings.com’s user-friendly platform allows customers to easily search, select, and reserve their ideal glamping accommodation without incurring additional reservation fees. By focusing on providing unparalleled glamping options, the company caters to a growing market of travelers seeking distinctive and comfortable outdoor experiences.

AMT Medical

Series B in 2025
AMT Medical B.V., established in 2015 and located in Ede, the Netherlands, specializes in the development of innovative medical devices for heart bypass surgery. The company's flagship product, the AMT Heart Bypass System, utilizes a minimal invasive technique known as the ELANA bypass, which was invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team. This advanced technology aims to enhance traditional heart bypass procedures by making them faster, safer, and less invasive, thereby improving patient outcomes and reducing complications. AMT Medical has completed the full development of its product and the production process, with all pre-clinical trials successfully concluded. The company is also preparing to initiate a clinical multi-center trial to further validate the technology's efficacy.

Grassa

Venture Round in 2025
Grassa BV specializes in the valorization of plant-based streams through bioraffinage. Based in the Netherlands, Grassa converts grass and vegetable waste into high-quality, protein-rich animal feed and other valuable products using its mobile bio-refinery technology. This process generates four main outputs: fibers, protein, phosphate, and 'wei' (sap). By transforming locally available green residual flows such as grass from meadows, agricultural waste, water plants, or nature grass, Grassa supports sustainable agriculture and helps farmers enhance their income while addressing food scarcity.

Cano-ela

Seed Round in 2025
Cano-ela is a food technology company focused on enhancing the food supply chain by eliminating refined ingredients. It specializes in processing oil-rich seeds, such as canola, to extract naturally occurring structures. The firm's innovative approach replaces conventional refined ingredients with mildly refined seed fractions, allowing clients to create natural emulsion-based food products that are environmentally sustainable and feature clean labels. Through its technology, Cano-ela aims to support the development of healthier food options while minimizing the ecological impact of food production.

Mair Therapeutics

Pre Seed Round in 2025
Mair Therapeutics is a biotechnology company focused on developing treatments for neurodegenerative disorders, with a particular emphasis on Parkinson's disease. The company's platform specializes in discovering small-molecule ion channel activators that regulate the lysosomal ion channel TMEM175, controlling lysosomal pH to degrade protein aggregates associated with these conditions. Currently, Mair Therapeutics is in the preclinical drug discovery phase.

OneThird

Series A in 2025
OneThird is a technology company focused on reducing food loss and waste through innovative IoT systems. It develops a cloud-based platform combined with handheld scanners that utilize artificial intelligence to enhance cold chain logistics. This enables retailers to scan fresh produce at distribution centers and stores, accurately predicting the remaining shelf life of items. By improving inventory management, OneThird helps retailers sell their products at the optimal time, significantly mitigating food wastage. The company's solutions are aligned with global sustainability goals, particularly in addressing the issue of food waste within the supply chain.

New Origin

Seed Round in 2025
New Origin operates as a photonic chips foundry to produce silicon nitride chips.

InsectSense

Pre Seed Round in 2025
InsectSense is a biotechnology firm focused on developing innovative solutions inspired by the natural sensory mechanisms of insects. Recognizing the advanced capabilities that have evolved over millions of years, the company aims to harness these biological insights to address significant global challenges. InsectSense's technology enables precise detection and measurement of low-concentration compounds, facilitating accurate diagnosis of novel diseases by allowing physicians to identify the unique "fingerprints" of volatile compounds from complex sample mixtures. Through its work, InsectSense seeks to create positive societal and environmental impacts worldwide by leveraging the inherent potential of insect-inspired sensing systems.

Alveron Pharma

Seed Round in 2024
Alveron Pharma is a biotechnology company focused on developing treatments for hemorrhagic stroke, a condition with significant unmet medical needs. Their lead drug candidate, OKL-1111, has shown promise in reducing hematoma expansion in preclinical mouse models of intracranial hemorrhage. This drug is designed as an injection solution that is ready to use, aiming to eliminate the need for complex pre-treatment processes. Alveron Pharma's technology centers around cyclodextrins and procoagulant cyclodextrins, which are used to create anticoagulant reversal drugs. These innovations target excessive bleeding in various contexts, including hemophilia, trauma, surgery, and bleeding related to the use of anticoagulants, thereby providing both acute and long-term therapeutic options for thromboembolic disorders.

RIFT

Series A in 2024
RIFT is a startup focused on advancing sustainability through clean and renewable energy solutions. The company has developed Iron Fuel Technology, which aims to significantly reduce the global carbon footprint in energy-intensive sectors. This innovative fuel offers a reliable source of fully renewable heat throughout the year, enabling industries with high energy consumption to actively participate in global decarbonization efforts. RIFT's commitment to sustainable practices positions it as a key player in the transition towards a greener future.

NoPalm-Ingredients

Seed Round in 2024
NoPalm Ingredients specializes in the production of sustainable microbial oils that serve as alternatives to palm and other tropical oils in the food and cosmetics industries. By utilizing fermentation technology, the company aims to eliminate the reliance on palm oil, addressing environmental concerns associated with its production. NoPalm Ingredients provides eco-friendly solutions that contribute to the reduction of greenhouse gas emissions and promote decarbonization throughout the value chain. This approach not only helps protect forests and wildlife but also supports healthier options for consumers and benefits local populations.

Hudson River Biotechnology

Venture Round in 2024
Hudson River Biotechnology is a biotechnology company focused on genetically optimizing plants to facilitate the production of high-value compounds. The company employs innovative breeding techniques to develop new plant traits and utilizes a unique genetic target identification platform alongside nano-delivery technologies. By anticipating and creating biotechnological solutions, Hudson River Biotechnology aims to support the transition to a sustainable bio-economy and enhance the agri-food supply chain. Its efforts are directed at providing clients with effective alternatives to traditional agrochemicals, which are increasingly being phased out in favor of more sustainable practices.

Hexwise

Pre Seed Round in 2024
Hexwise is a company that specializes in optimizing the performance and maintenance of air-cooled heat exchangers to enhance energy efficiency across various industrial applications. The company's innovative heat exchanger optimization software is designed to reduce energy wastage and inefficiencies, particularly in sectors such as thermal power plants, gas transport networks, and chemical facilities. By providing a monitoring system that integrates with existing heat exchangers, Hexwise enables maintenance and asset managers to gain valuable insights and recommendations. This approach helps businesses improve their energy efficiency and operational effectiveness.

Time-Travelling Milkman

Seed Round in 2024
Time-Travelling Milkman specializes in the production of plant-based cream derived from sunflower seeds, aimed at providing sustainable and appealing dairy alternatives. The company focuses on extracting ingredients from seeds and research-driven plant-based materials, allowing consumers to enjoy creamy and flavorful options while minimizing environmental impact. Through its innovative approach, Time-Travelling Milkman contributes to the growing demand for healthier and more sustainable food choices in the dairy alternative market.

Brilliance

Seed Round in 2023
Brilliance specializes in the development of micro laser modules designed for augmented reality displays. The company utilizes a visual silicon-nitride-based platform that aims to provide superior technical performance while facilitating high-quality, low-cost volume production. By delivering advanced light engines for projection applications through its innovative chip technology, Brilliance addresses critical challenges such as miniaturization, integration, energy efficiency, and user comfort in augmented reality projection.

Scope Biosciences

Seed Round in 2023
Scope Biosciences is a company focused on developing molecular diagnostics through the use of CRISPR-Cas technology. As a spin-off from Wageningen University & Research, it operates a platform that provides innovative and accessible diagnostic tests for infectious diseases and genetic traits. The company's offerings include rapid, on-site tests that are designed to be sensitive, specific, and affordable. By enabling customers to obtain timely and accurate health information, Scope Biosciences aims to empower individuals to make informed decisions about their health and well-being.

SuperLight Photonics

Seed Round in 2023
SuperLight Photonics is a technology company that specializes in the development of advanced laser systems. Their core product is a supercontinuum generation laser, designed to serve as a versatile light source for various applications, including advanced spectroscopy, biomedical imaging, industrial inspection, and environmental sensing. This laser enables scientists, engineers, and professionals in fields like research and healthcare to study ultrafast molecular processes with high precision.

Tagworks Pharmaceuticals

Series A in 2023
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands, established in 2011 as a spin-out from Philips Healthcare. The company focuses on developing innovative in vivo chemistry to enhance the effectiveness of cancer therapies and to facilitate novel companion diagnostics. Operating from the Radboud University Medical Center in Nijmegen, Tagworks specializes in antibody-based imaging and therapy technologies. Its proprietary approach allows for the selective chemical manipulation of tagged antibodies in vivo, which improves the efficacy of established methods like radioimmuno-imaging and antibody-drug conjugates. This technology enables medical professionals to conduct imaging with significantly reduced radiation exposure for patients.

Delta Life Science

Series A in 2023
Delta Diagnostics, founded in 2018 as a spin-off from TNO – The Netherlands Organisation for Applied Scientific Research, specializes in the commercialization of advanced biosensor technology. The company focuses on developing photonic biosensors that integrate optical chips with waveguides to facilitate multiplexed biosensing. This technology enables real-time monitoring through highly sensitive refractive index sensors, allowing for label-free biosensing. Delta Diagnostics aims to provide rapid, sensitive, and cost-effective solutions that can significantly enhance research in the Life Sciences sector. By enabling accurate measurement of multiple biomarkers within minutes, the company aspires to drive new discoveries and foster the development of innovative diagnostics.

revyve

Series A in 2023
Revyve is a company that specializes in producing animal-free food ingredients derived from microorganisms. Its product offerings include premium emulsifiers, heat-set gels, and foaming agents, designed to serve as effective replacements for traditional animal-based ingredients. By focusing on the development of innovative food solutions, Revyve aims to meet the growing demand for sustainable and health-conscious alternatives in the food industry. The company provides tailored ingredients that address specific protein functionality requests, allowing customers to create great-tasting foods without sacrificing taste, texture, or nutritional value.

PEF Technologies

Venture Round in 2023
PEF Technologies specializes in non-thermal food processing through its innovative application of nanosecond pulsed electric field technology. This method offers an alternative to traditional pasteurization, enhancing food and beverage preservation while maintaining flavor and nutritional integrity. By utilizing short-duration, high-intensity electric fields, PEF Technologies effectively extends the shelf life of products, such as juice, without compromising their bioavailability and bioaccessibility. The company's approach not only preserves the quality of nutritious components but also aims to reduce energy consumption in food processing, positioning it as a leader in sustainable food technology solutions.

OneThird

Seed Round in 2023
OneThird is a technology company focused on reducing food loss and waste through innovative IoT systems. It develops a cloud-based platform combined with handheld scanners that utilize artificial intelligence to enhance cold chain logistics. This enables retailers to scan fresh produce at distribution centers and stores, accurately predicting the remaining shelf life of items. By improving inventory management, OneThird helps retailers sell their products at the optimal time, significantly mitigating food wastage. The company's solutions are aligned with global sustainability goals, particularly in addressing the issue of food waste within the supply chain.

Pro Parents

Pre Seed Round in 2023
Operator of an employer benefit platform intended for parents at work. The company's platform provides training, coaching and improvement programs which include providing maternal and paternal health and workplace wellbeing services, enabling employers to create a healthy work culture and living.

ArthroSave

Seed Round in 2023
ArthroSave specializes in joint-preserving surgical procedures aimed at younger patients suffering from knee osteoarthritis. The company has developed a medical device that addresses knee injuries and facilitates joint-saving treatments. This innovative device allows orthopedic surgeons to perform safe and painless knee replacements while maintaining the original alignment of bones and tissues. By focusing on patients under sixty-five years old with persistent knee joint damage, ArthroSave aims to improve the quality of life for individuals with knee issues, providing effective solutions tailored to their needs.

LioniX International

Venture Round in 2023
LioniX International specializes in the development and manufacturing of photonic microsystems and optical devices, focusing on customized solutions for original equipment manufacturers and system integrators. The company utilizes its expertise in Photonic Integrated Circuits, micro-electromechanical systems (MEMS), and opto-fluidics to offer products that range from design to fully assembled modules. By leveraging vertical integration and scalable production capabilities, LioniX International ensures that its clients in the telecommunications industry have access to advanced micro-nanotechnology solutions. The company maintains a strong position in technology leadership through a robust intellectual property portfolio.

Aiosyn

Seed Round in 2022
Aiosyn is a company that specializes in the development of artificial intelligence algorithms to enhance pathology diagnostics, particularly in cancer and chronic kidney diseases. By utilizing a modular software-as-a-service model, Aiosyn integrates its algorithms into existing pathology workflows, facilitating greater accuracy and efficiency in diagnostic processes. The company's platform fosters collaboration between pathologists and AI, leveraging computational pathology technology to support informed decision-making in both clinical diagnostics and drug development. Through its innovative solutions, Aiosyn aims to improve the precision of diagnoses and ultimately enhance the survival rates of patients with cancer and chronic kidney diseases.

SAIA Agrobotics

Seed Round in 2022
SAIA Agrobotics is a developer of autonomous robots aimed at transforming food production in the greenhouse horticulture sector. The company focuses on creating innovative harvest and crop-handling robots, along with artificial intelligence-driven harvesting systems specifically designed for indoor farming. By automating key agricultural tasks, SAIA Agrobotics addresses pressing challenges such as climate change and food security, enabling farmers to operate in controlled environments. This approach allows for improved crop yields while optimizing land use, making indoor farming more accessible and affordable. Through its advancements, SAIA Agrobotics seeks to enhance the efficiency of food production and contribute to sustainable agricultural practices.

Secret View

Series A in 2022
Secret View is a community platform focused on enhancing customer experience through feedback and insights. It enables users to publish their assignments and facilitates a process of becoming proficient feedback providers by offering e-learning, personal support, and quality checks. Additionally, Secret View operates as a market research agency, providing organizations with affordable solutions to continuously learn from real customer experiences. By utilizing mystery shopping research, the company assists retail and hospitality chains in measuring and optimizing their customer service, thereby enhancing overall business performance.

Enzyre

Series A in 2022
Enzyre is a developer of innovative diagnostic technology aimed at enhancing patient care through point-of-care solutions. The company specializes in ambulant diagnostic devices that facilitate blood coagulation testing, allowing patients to perform up to twelve different reactions using a small volume of blood. This technology is designed to empower patients to conduct tests in various settings, including at home, while traveling, or in critical care environments, all without the need for traditional laboratory infrastructure. By bringing laboratory capabilities directly to the patient, Enzyre seeks to improve quality of life while maintaining cost-effectiveness in healthcare.

Fiber Unlimited

Seed Round in 2022
Fiber Unlimited specializes in products and services for indoor Plastic Optical Fiber (POF) networks, focusing on the development of telecom solutions based on optical technology. The company designs in-house products that integrate fiber-access technologies to create a comprehensive managed optical network. This network solution aims to provide a reliable, fast, and sustainable internet connection suitable for both professional and residential use. By enabling efficient communication, Fiber Unlimited addresses the growing demand for high-quality indoor network services.

Borg Energy Storage

Series A in 2022
Borg Energy Storage is focused on developing sustainable thermal energy solutions for residential buildings. The company has created a heat storage system that utilizes solar collectors to heat water during the summer months, which is then stored in a buffer tank located beneath the house or in the garden. This innovative approach allows homeowners to retain and utilize heat during the winter, enhancing energy efficiency. In addition, Borg Energy Storage provides energy management software to optimize energy use, promoting both sustainability and cost savings for users. The company's solutions are designed to improve the overall comfort and energy performance of homes.

Enliven

Venture Round in 2022
You can experience what it's like to be in someone else's shoes with Enliven's virtual reality experiences. a realistic experience that enables you to view the world from a different angle.

Pleco Therapeutics

Series A in 2022
Pleco Therapeutics is a biopharmaceutical company focused on developing innovative therapies for cancer, particularly targeting orphan cancer treatments. The firm is currently engaged in pre-clinical development of its patented Plecoid medications, aiming to improve outcomes for patients with Acute Myeloid Leukaemia (AML) and Small-Cell Lung Cancer (SCLC), both of which have poor prognoses. By enhancing the effectiveness of existing chemotherapy and altering protein expression within the cancer microenvironment, Pleco Therapeutics seeks to extend the lifespan and improve the quality of life for patients. Additionally, the company aims to alleviate the burden of toxic metals within cancer cells, thereby addressing not only the disease itself but also its underlying causes.

PHIX

Debt Financing in 2022
PHIX is a packaging foundry that supplies the photonics industry with assembly and packaging services. PHIX develops optoelectronic modules on all major PIC technology platforms, including indium phosphide, silicon photonics, silicon nitride, and planar lightwave circuit. PHIX specializes in chip-to-chip hybrid integration, fiber array coupling, and the interfacing of DC and RF electrical signals.

PHIX

Venture Round in 2022
PHIX is a packaging foundry that supplies the photonics industry with assembly and packaging services. PHIX develops optoelectronic modules on all major PIC technology platforms, including indium phosphide, silicon photonics, silicon nitride, and planar lightwave circuit. PHIX specializes in chip-to-chip hybrid integration, fiber array coupling, and the interfacing of DC and RF electrical signals.

QuiX

Seed Round in 2022
QuiX BV, located in Enschede, the Netherlands, specializes in the development of integrated and reconfigurable light-based quantum processors. The company focuses on quantum information processing through its proprietary TriPleX platform, which utilizes stoichiometric Si3N4 waveguides. QuiX offers plug-and-play solutions that enable stable and efficient processing of single photons, facilitating advancements in quantum computing. By providing both integrated photonic processors and customized devices, QuiX aims to contribute significantly to the evolution of quantum technologies, paving the way for a transformative approach to information processing.

Corvus Drones

Seed Round in 2022
Corvus Drones specializes in autonomous drone applications tailored for the agricultural sector, including horticulture, crop monitoring, and pest recognition. The company’s innovative technology allows for efficient data collection and analysis, providing drone operators with detailed reports within an hour of operation. By streamlining agricultural processes, Corvus Drones aims to enhance production sustainability, reducing energy consumption, labor, pollution, and overall costs while simultaneously improving yield outcomes.

Clairify

Seed Round in 2022
Clairify is a company dedicated to enhancing tenant-landlord relations by focusing on the creation of productive and energy-efficient workplaces. It develops indoor climate measurement sensors that monitor air quality and comfort levels in various environments, such as schools and offices. By utilizing predictive analytics, Clairify aims to improve indoor environments, thereby increasing the well-being and productivity of building occupants. The company provides timely insights and recommendations for facility management enhancements, ultimately adding value to buildings, reducing maintenance costs, and ensuring compliance with indoor air quality regulations. Through these efforts, Clairify contributes to the development of healthy workspaces that foster better tenant experiences.

Pro Parents

Pre Seed Round in 2022
Operator of an employer benefit platform intended for parents at work. The company's platform provides training, coaching and improvement programs which include providing maternal and paternal health and workplace wellbeing services, enabling employers to create a healthy work culture and living.

Aiosyn

Pre Seed Round in 2022
Aiosyn is a company that specializes in the development of artificial intelligence algorithms to enhance pathology diagnostics, particularly in cancer and chronic kidney diseases. By utilizing a modular software-as-a-service model, Aiosyn integrates its algorithms into existing pathology workflows, facilitating greater accuracy and efficiency in diagnostic processes. The company's platform fosters collaboration between pathologists and AI, leveraging computational pathology technology to support informed decision-making in both clinical diagnostics and drug development. Through its innovative solutions, Aiosyn aims to improve the precision of diagnoses and ultimately enhance the survival rates of patients with cancer and chronic kidney diseases.

Prolira BV

Venture Round in 2022
Prolira BV is a medical technology company based in Utrecht, the Netherlands, founded in 2015. It specializes in developing DeltaScan, an innovative EEG-based medical device designed for the early detection of delirium, a form of acute brain failure. The DeltaScan system comprises a single-use electrode patch known as the DeltaScan Patch and a hardware/software module called the DeltaScan Monitor, which analyzes brain activity to support clinical decision-making. Prolira is dedicated to enabling timely and effective treatment for acute encephalopathy and delirium, conditions that affect approximately 20 million patients annually in hospitals across the European Union and the United States. By providing the first EEG bedside device with a validated proprietary algorithm, Prolira aims to help clinicians optimize patient recovery, ultimately reducing long-term cognitive impairment and hospital costs.

Bilihome B.V.

Seed Round in 2022
Bilihome aims to provide an ordinary-looking romper or vest for newborns, which enables natural care and free bonding during jaundice therapy in the first week of life. The embedded smart wearables and the miniaturized system simplify the logistics and encourage care outside the hospital.

River BioMedics

Seed Round in 2022
River BioMedics is a biotechnology company focused on developing 3D human heart tissue for pre-clinical drug testing. Recognizing that pharmaceutical companies face significant challenges in drug development, including high costs and a 90% failure rate primarily due to drug-induced cardiac toxicity, River BioMedics aims to address these issues by creating advanced 3D cardiac models. These models closely mimic the functioning human heart and are designed to provide clinically relevant insights during drug discovery and toxicity screening. By utilizing a multidisciplinary approach based on human stem cells, the company offers innovative tools for healthcare professionals to validate drug targets and enhance the understanding of how various compounds affect cardiac function.

ATRO Medical

Venture Round in 2021
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of anatomically shaped polymer meniscus implants, specifically the Trammpolin. This innovative prosthesis is designed to replace damaged menisci, restoring their protective function by acting as a joint spacer and shock absorber. The Trammpolin mimics the natural meniscus, facilitating adequate load distribution within the knee joint, which can provide significant relief for osteoarthritis patients suffering from severe pain. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise from a public-private collaboration initiated in 2010 that involved various universities, private companies, and support from the Dutch government. This collaborative effort has been instrumental in the design and development of the Trammpolin prototype.

Fring

Seed Round in 2021
Fring is a hiring platform designed to transform the freelance recruitment process by connecting businesses with a diverse range of freelance talent. The company offers organizations a real-time resource for accessing skilled professionals, including designers, developers, marketers, and media experts. By facilitating these connections, Fring enables companies to assemble flexible teams while providing freelancers with opportunities to engage in challenging projects. This approach aims to streamline the process of finding and hiring freelance talent, making it more efficient for both businesses and individuals seeking work.

Alveron Pharma

Seed Round in 2021
Alveron Pharma is a biotechnology company focused on developing treatments for hemorrhagic stroke, a condition with significant unmet medical needs. Their lead drug candidate, OKL-1111, has shown promise in reducing hematoma expansion in preclinical mouse models of intracranial hemorrhage. This drug is designed as an injection solution that is ready to use, aiming to eliminate the need for complex pre-treatment processes. Alveron Pharma's technology centers around cyclodextrins and procoagulant cyclodextrins, which are used to create anticoagulant reversal drugs. These innovations target excessive bleeding in various contexts, including hemophilia, trauma, surgery, and bleeding related to the use of anticoagulants, thereby providing both acute and long-term therapeutic options for thromboembolic disorders.

Xenikos

Convertible Note in 2021
Xenikos is a biopharmaceutical company focused on developing innovative immunotherapy treatments aimed at restoring health to patients suffering from serious immune diseases and transplant rejection. The company specializes in creating anti-T-cell antibodies that act as a therapeutic tool to reset the immune system. Once administered, these antibodies specifically target and eliminate activated adult T cells, allowing for improved treatment outcomes in various medical conditions. By harnessing the potential of antibody action, Xenikos aims to provide efficient solutions that can significantly enhance patient recovery and overall well-being.

ScreenPoint Medical

Series C in 2021
ScreenPoint Medical B.V. is a company based in Nijmegen, the Netherlands, specializing in the development of artificial intelligence software designed to assist radiologists in interpreting digital breast tomosynthesis (DBT) and mammography exams. Founded in 2014, ScreenPoint focuses on creating deep learning and image analysis technologies that enhance the accuracy and consistency of breast cancer detection. By leveraging advanced machine learning techniques alongside extensive, well-curated digital image databases, the company aims to improve the diagnostic process for breast cancer, thereby enabling earlier detection and reducing unnecessary patient recalls. Their flagship product, Transpara, exemplifies this commitment to enhancing clinical outcomes in mammography through innovative technology.

Time-Travelling Milkman

Pre Seed Round in 2021
Time-Travelling Milkman specializes in the production of plant-based cream derived from sunflower seeds, aimed at providing sustainable and appealing dairy alternatives. The company focuses on extracting ingredients from seeds and research-driven plant-based materials, allowing consumers to enjoy creamy and flavorful options while minimizing environmental impact. Through its innovative approach, Time-Travelling Milkman contributes to the growing demand for healthier and more sustainable food choices in the dairy alternative market.

OneThird

Seed Round in 2021
OneThird is a technology company focused on reducing food loss and waste through innovative IoT systems. It develops a cloud-based platform combined with handheld scanners that utilize artificial intelligence to enhance cold chain logistics. This enables retailers to scan fresh produce at distribution centers and stores, accurately predicting the remaining shelf life of items. By improving inventory management, OneThird helps retailers sell their products at the optimal time, significantly mitigating food wastage. The company's solutions are aligned with global sustainability goals, particularly in addressing the issue of food waste within the supply chain.

Corvus Drones

Seed Round in 2021
Corvus Drones specializes in autonomous drone applications tailored for the agricultural sector, including horticulture, crop monitoring, and pest recognition. The company’s innovative technology allows for efficient data collection and analysis, providing drone operators with detailed reports within an hour of operation. By streamlining agricultural processes, Corvus Drones aims to enhance production sustainability, reducing energy consumption, labor, pollution, and overall costs while simultaneously improving yield outcomes.

PESCHECK

Convertible Note in 2021
Globalization, a hybrid workforce and increasing demand from risk and compliance changed the future of employment rapidly. PESCHECK provides information and insights that make trust possible and ensure that each employee is reliably represented. By creating an actionable and robust picture of each employee. PESCHECK is the all-in-one software designed to accelerate your onboarding process with digital, fast and automated background checks. Creating a user-friendly and secure candidate experience and saves time. #automated background checks #background checks #backgroud screening #background check software #pre employment screening #in employment screening #freelancer screening #backgroud checks API #hrtech #regtech #KYE

InteRNA Technologies

Series B in 2021
InteRNA Technologies B.V. is a biotechnology company focused on developing microRNA (miRNA)-based therapeutics for cancer treatment. Founded in 2006 and headquartered in Nijmegen, the Netherlands, with a research and development center in Utrecht, the company leverages its proprietary technology to discover and validate miRNA sequences that can target multiple signaling pathways involved in cancer initiation, progression, and metastasis. By addressing previously undruggable targets, InteRNA aims to enhance the efficacy of existing cancer therapies and reduce the development of drug resistance. The company employs advanced bioinformatics and massively parallel sequencing techniques to analyze miRNA functions, paving the way for innovative treatment options in oncology.

Eurekite

Venture Round in 2021
Eurekite BV, based in Enschede, the Netherlands, specializes in the manufacture of flexible ceramic materials. Established in May 2015 as a spin-off from the University of Twente, the company focuses on the development and commercialization of its innovative technology, known as Flexiramics®. This technology emerged from the Inorganic Materials Science Group of the MESA + Institute for Nanotechnology, led by Professor Andre ten Elshof. Eurekite combines expertise in formulation chemistry, production technology, and composite development, with its disruptive materials attracting investment from prominent venture capital firms.

Pepscope

Venture Round in 2020
Pepscope BV is a biotechnology company based in Nijmegen, the Netherlands, specializing in the development of innovative protein kinase activity profiling technologies. Founded in 2012, the company focuses on creating solutions that enhance the discovery and development of novel kinase inhibitors and other therapeutic compounds. Pepscope offers its flagship product, QuantaKinome, to the pharmaceutical industry and academic researchers, facilitating the identification of new applications for existing compounds and aiding in the selection of optimal therapies tailored to individual patients. In addition to kinase profiling assays, Pepscope provides advanced proteomics services, utilizing microarray and mass spectrometry techniques to deliver reproducible results and robust conclusions for research and diagnostics.

NutriLeads

Series B in 2020
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Gatt

Series B in 2020
GATT Technologies BV, established in 2011 and headquartered in Nijmegen, the Netherlands, specializes in developing innovative medical devices. The company focuses on creating synthetic surgical hemostat and sealant products designed to control severe bleeding and organ leakages during surgical procedures. Their product portfolio includes GATT-Patch, a hemostatic sealing patch for general surgery; GATT-Tape, an adhesive tape for preventing intestinal anastomotic leakage; GATT-Spray, an elastic sealant for general surgery; and GATT-Powder, a hemostatic sealing powder. These products are based on a patented synthetic technology, aiming to address challenging surgical bleeding and leakage issues.

Textmetrics

Seed Round in 2019
Textmetrics is a developer of a content quality platform that enhances the effectiveness of content delivery for organizations. By employing machine learning and artificial intelligence, the platform offers real-time suggestions to assist clients in crafting engaging content tailored to their target audience. This innovative approach enables organizations to maintain consistency in their messaging while continuously improving the conversion rates of both online and offline texts. Through augmented assisted writing based on scientifically proven algorithms, Textmetrics aims to ensure that every word counts in achieving optimal communication outcomes.

PESCHECK

Seed Round in 2019
Globalization, a hybrid workforce and increasing demand from risk and compliance changed the future of employment rapidly. PESCHECK provides information and insights that make trust possible and ensure that each employee is reliably represented. By creating an actionable and robust picture of each employee. PESCHECK is the all-in-one software designed to accelerate your onboarding process with digital, fast and automated background checks. Creating a user-friendly and secure candidate experience and saves time. #automated background checks #background checks #backgroud screening #background check software #pre employment screening #in employment screening #freelancer screening #backgroud checks API #hrtech #regtech #KYE

Prolira BV

Seed Round in 2018
Prolira BV is a medical technology company based in Utrecht, the Netherlands, founded in 2015. It specializes in developing DeltaScan, an innovative EEG-based medical device designed for the early detection of delirium, a form of acute brain failure. The DeltaScan system comprises a single-use electrode patch known as the DeltaScan Patch and a hardware/software module called the DeltaScan Monitor, which analyzes brain activity to support clinical decision-making. Prolira is dedicated to enabling timely and effective treatment for acute encephalopathy and delirium, conditions that affect approximately 20 million patients annually in hospitals across the European Union and the United States. By providing the first EEG bedside device with a validated proprietary algorithm, Prolira aims to help clinicians optimize patient recovery, ultimately reducing long-term cognitive impairment and hospital costs.

Plasmacure

Seed Round in 2018
Plasmacure, headquartered in Eindhoven, Netherlands, is a medical technology company focused on developing innovative solutions for chronic wound healing, with a particular emphasis on diabetic foot wounds. The company's core product is a patented cold plasma solution designed to kill bacteria, stimulate cell proliferation, and improve microcirculation, thereby reducing the risk of amputation and enhancing patients' quality of life.

Mimetas

Series B in 2018
MIMETAS B.V., founded in 2013 and based in Leiden, the Netherlands, specializes in the development of microfluidics-based culture plates designed for the cultivation and screening of three-dimensional organ and tissue models. The company's product line includes OrganoPlate 2-lane and 3-lane systems, which facilitate early-stage screening for drug efficacy and toxic side effects. By addressing the discrepancies between traditional in vitro and animal models and actual patient responses, MIMETAS aims to enhance the predictability of drug testing. Its OrganoPlates enable high-throughput screening of customized disease, toxicology, and transport models, thereby providing researchers and clinicians with innovative tools for compound testing and fundamental research.

SuperBuddy

Venture Round in 2017
SuperBuddy is an on-demand grocery delivery service based in the Netherlands. The company operates an online marketplace that allows users to shop for groceries from local stores. By connecting customers with personal shoppers, SuperBuddy facilitates a tailored shopping experience where users can specify their preferences. The platform ensures timely delivery, typically within a two-hour window, enabling customers to conveniently receive their selected items at their doorstep.

SoundEnergy

Venture Round in 2017
Sound Energy BV is focused on developing and commercializing innovative technologies aimed at reducing fossil energy consumption. The company specializes in Thermo Acoustic Technology, which provides a sustainable solution for climate control in buildings. By utilizing hot water for cooling, Sound Energy's heat engines and heat pumps eliminate the need for electricity or gas, allowing homeowners to manage energy consumption while achieving zero carbon dioxide emissions. With a commitment to sustainability, the company integrates environmental considerations with scientific expertise and a pragmatic business approach, ensuring that its technologies serve both ecological and economic interests.

Mellon Medical

Series B in 2017
Mellon Medical B.V., established in 2013 and based in Nijmegen, the Netherlands, specializes in the development and marketing of innovative medical suturing tools designed for surgeons. The company focuses on enhancing healthcare treatment procedures by providing advanced surgical instruments that enable single-handed stitching. This unique capability allows medical specialists to perform efficient and effective suturing of tubular and layered structures, ultimately aiming to improve patient outcomes during surgical procedures. Through its commitment to innovation in surgical technology, Mellon Medical seeks to support healthcare professionals in delivering high-quality care.

Textmetrics

Seed Round in 2017
Textmetrics is a developer of a content quality platform that enhances the effectiveness of content delivery for organizations. By employing machine learning and artificial intelligence, the platform offers real-time suggestions to assist clients in crafting engaging content tailored to their target audience. This innovative approach enables organizations to maintain consistency in their messaging while continuously improving the conversion rates of both online and offline texts. Through augmented assisted writing based on scientifically proven algorithms, Textmetrics aims to ensure that every word counts in achieving optimal communication outcomes.

ThermoSmart

Venture Round in 2017
ThermoSmart is a Dutch company that specializes in the development of a user-friendly Wi-Fi thermostat aimed at energy conservation. The thermostat operates independently from energy suppliers and boiler installers, allowing users to manage their home heating efficiently. It can be controlled via an online diary or directly from a smartphone, providing convenience and flexibility. By focusing on ease of use and energy savings, ThermoSmart offers a solution that helps consumers reduce their heating costs while maintaining comfort in their homes.

Xenikos

Series A in 2012
Xenikos is a biopharmaceutical company focused on developing innovative immunotherapy treatments aimed at restoring health to patients suffering from serious immune diseases and transplant rejection. The company specializes in creating anti-T-cell antibodies that act as a therapeutic tool to reset the immune system. Once administered, these antibodies specifically target and eliminate activated adult T cells, allowing for improved treatment outcomes in various medical conditions. By harnessing the potential of antibody action, Xenikos aims to provide efficient solutions that can significantly enhance patient recovery and overall well-being.

ChargeNet

B2B e-truck charging platform
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.